IGFBP2 and acute myeloid leukemia: We observed that IGFBP2 manifested a significant positive association with the expression of FTO in AML cohorts from the TCGA database (Additional file 1: Fig. S5G) and our in-house t(8;21) AML cohorts (Fig. 5I).